CLINICAL_TRIALS
trial_result
· 2012-03-12
Clinical Trial Update: Apremilast in the Treatment of Moderate to Severe Acne [Phase 2]
Summary
A Phase 2 trial of apremilast for moderate-to-severe acne was terminated, with results posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of North Carolina, Chapel Hill | Conditions: Acne | Phase 2 | Status: TERMINATED | Results posted: 2012-03-12